PI
PTLA

PEAK6 Investments’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

PEAK6 Investments’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-49,116
Closed -$884K – 5164
2020
Q2 		$884K Buy
+49,116
New +$683K ﹤0.01% 2197

PEAK6 Investments's PTLA Position: Q3 2020 in Review

PEAK6 Investments sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 49,116 shares — an estimated $884K sold.

PEAK6 Investments first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $884K in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • PEAK6 Investments reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • PEAK6 Investments sold 49,116 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $884K.
  • PEAK6 Investments first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • PEAK6 Investments's Portola Pharmaceuticals, Inc. position peaked at $884K in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on PEAK6 Investments's 13F filing for Q3 2020, filed 13 Nov 2020.